PAPAIJV
ASPI icon

Paragon Associates & Paragon Associates II Joint Venture’s ASP Isotopes ASPI Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio ASPI Stock Details ASPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,000
Closed -$113K – 14
2024
Q4 		$113K Buy
+25,000
New +$133K 0.26% 12

Other funds holding ASPI

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PFMOSF
Philadelphia Financial Management of San Francisco San Francisco, California $346M AUM 30.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's ASPI Position: Q1 2025 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of ASP Isotopes (ASPI) in Q1 2025, closing a stake of 25,000 shares — an estimated $113K sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in ASPI in Q4 2024 and held it in 1 quarter. The position peaked at $113K in Q4 2024. 99 funds tracked by Wall St. Rank hold ASPI as of Q1 2025.

  • Paragon Associates & Paragon Associates II Joint Venture reported no remaining ASP Isotopes position as of Q1 2025 after selling out during the quarter.
  • Paragon Associates & Paragon Associates II Joint Venture sold 25,000 ASP Isotopes shares in Q1 2025, an estimated $113K.
  • Paragon Associates & Paragon Associates II Joint Venture first reported a position in ASP Isotopes in Q4 2024 and held it in 1 quarter.
  • Paragon Associates & Paragon Associates II Joint Venture's ASP Isotopes position peaked at $113K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2025.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2025, filed 13 May 2025.